| Literature DB >> 27825618 |
Daniel P Morin1, Michael L Bernard2, Christopher Madias3, Paul A Rogers2, Sudarone Thihalolipavan2, N A Mark Estes4.
Abstract
As the most common sustained arrhythmia in adults, atrial fibrillation (AF) is an established and growing epidemic. To provide optimal patient care, it is important for clinicians to be aware of AF's epidemiological trends, methods of risk reduction, and the various available treatment modalities. Our understanding of AF's pathophysiology has advanced, and with this new understanding has come advancements in prevention strategies as well as pharmacological and nonpharmacological treatment options. Following PubMed and MEDLINE searches for AF risk factors, epidemiology, and therapies, we reviewed relevant articles (and bibliographies of those articles) published from 2000 to 2016. This "state-of-the-art" review provides a comprehensive update on the understanding of AF in the world today, contemporary therapeutic options, and directions of ongoing and future study. Copyright ÂEntities:
Mesh：
Substances：
Year: 2016 PMID： 27825618 DOI： 10.1016/j.mayocp.2016.08.022
Source DB: PubMed Journal: Mayo Clin Proc ISSN： 0025-6196 Impact factor: 7.616